Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-01-27

Clinical Trial Update: Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging Study [NA]

View source ↗

Summary

A clinical trial investigating brain insulin resistance in Alzheimer’s disease and mild cognitive impairment using intranasal insulin; the study status is withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intranasal insulin (insulin)

Snippet

Sponsor: Erasme University Hospital | Conditions: Alzheimer Disease, Mild Cognitive Impairment | NA | Status: WITHDRAWN